Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Philip Morris
PM
|
+$339M |
| 3 |
DuPont de Nemours
DD
|
+$270M |
| 4 |
Altria Group
MO
|
+$268M |
| 5 |
Fox Class A
FOXA
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$513M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$362M |
| 3 |
Merck
MRK
|
+$350M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$277M |
| 5 |
Pfizer
PFE
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 12.8% |
| 3 | Consumer Discretionary | 11.91% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZAYO
1701
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $7.28M | ﹤0.01% |
256,085
-67,499
| -21% | -$1.79M |
|
1702
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$435M
| $7.23M | ﹤0.01% |
143,198
-125,716
| -47% | -$6.13M |
|
1703
Plains All American Pipeline
PAA
$17.1B
| $7.22M | ﹤0.01% |
294,717
-41,530
| -12% | -$982K |
|
1704
BioCryst Pharmaceuticals
BCRX
$2.23B
| $7.19M | ﹤0.01% |
882,910
-121,815
| -12% | -$1.04M |
|
1705
MYR Group
MYRG
$5.28B
| $7.18M | ﹤0.01% |
207,442
-8,799
| -4% | -$286K |
|
|
ODP
1706
DELISTED
ODP
ODP
| $7.17M | ﹤0.01% |
197,561
-23,249
| -11% | -$746K |
|
1707
Evertec
EVTC
$1.93B
| $7.16M | ﹤0.01% |
257,435
-160,556
| -38% | -$4.54M |
|
|
CNH
1708
CNH Industrial
CNH
$13.7B
| $7.14M | ﹤0.01% |
804,698
+153,010
| +23% | +$1.37M |
|
1709
Resideo Technologies
REZI
$5.39B
| $7.13M | ﹤0.01% |
369,761
+21,821
| +6% | +$484K |
|
|
PPT
1710
Franklin Premier Income Trust
PPT
$327M
| $7.13M | ﹤0.01% |
1,384,669
+85,320
| +7% | +$426K |
|
1711
Gates Industrial Corporation Ltd.
GTES
$7.27B
| $7.12M | ﹤0.01% |
496,666
+56,368
| +13% | +$850K |
|
1712
Fresenius Medical Care
FMS
$13.8B
| $7.11M | ﹤0.01% |
175,344
+6,875
| +4% | +$256K |
|
|
CMBT
1713
CMB.TECH NV
CMBT
$4.7B
| $7.1M | ﹤0.01% |
871,368
-909,373
| -51% | -$7.13M |
|
|
EHI
1714
Western Asset Global High Income Fund
EHI
$176M
| $7.09M | ﹤0.01% |
755,356
-85,362
| -10% | -$788K |
|
|
GTLS
1715
DELISTED
Chart Industries
GTLS
| $7.09M | ﹤0.01% |
78,328
-20,391
| -21% | -$1.65M |
|
1716
SPDR Gold Trust
GLD
$131B
| $7.08M | ﹤0.01% |
58,000
| – | – |
|
|
CY
1717
DELISTED
Cypress Semiconductor
CY
| $7.07M | ﹤0.01% |
473,640
-392,993
| -45% | -$5.7M |
|
1718
ANI Pharmaceuticals
ANIP
$1.79B
| $7.07M | ﹤0.01% |
100,156
-14,300
| -12% | -$841K |
|
1719
8x8 Inc
EGHT
$295M
| $7.06M | ﹤0.01% |
349,700
-47,061
| -12% | -$920K |
|
1720
Heron Therapeutics
HRTX
$97.9M
| $7.05M | ﹤0.01% |
288,671
-214
| -0.1% | -$5.6K |
|
|
PTLA
1721
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.05M | ﹤0.01% |
203,230
+10,905
| +6% | +$315K |
|
1722
Green Plains
GPRE
$1.14B
| $7.04M | ﹤0.01% |
422,174
-29,350
| -7% | -$440K |
|
1723
AeroVironment
AVAV
$7.91B
| $7.04M | ﹤0.01% |
102,861
-13,998
| -12% | -$1.06M |
|
1724
Royal Gold
RGLD
$16.9B
| $7.02M | ﹤0.01% |
77,211
-55,437
| -42% | -$4.84M |
|
1725
Gentherm
THRM
$1.25B
| $7.01M | ﹤0.01% |
190,300
+9,456
| +5% | +$385K |
|
Similar funds
Invesco's Q1 2019 Portfolio in Review
As of Q1 2019, Invesco held 3,988 positions worth $297B, up 14% from $261B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2019 filing shows 172 new, 1,740 increased, 1,658 reduced and 285 closed positions. Its largest new stake was Fox Class A: 4,126,302 shares worth $151M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Invesco's largest Q1 2019 buy was Fox Class A: 4,126,302 shares worth $151M.
- Invesco added most to Apple in Q1 2019, an estimated $381M increase.
- Invesco's biggest Q1 2019 reduction was Merck, cutting an estimated $350M.
- Invesco fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $513M.
- Invesco's ten largest holdings make up 17% of its $297B portfolio in Q1 2019.
- Invesco opened 172 new positions and closed 285 in Q1 2019.
- Invesco's portfolio value rose 14% quarter-over-quarter to $297B.
Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.